Emotional disorders

The key to depression may lie in our genes

Researchers have taken an in-depth look at the function of a gene that may be linked to the development of major depression. Their findings show that its activity levels might determine our susceptibility to stress and negative stimuli.

The key of how prone we are to depression may lie in our genes, researchers...
The key of how prone we are to depression may lie in our genes, researchers have found.
Source: pixabay/52Hertz

According to the National Institutes of Mental Health, major depression is a leading cause of disability among adults in the United States. Almost 7 percent of U.S. adults experienced episodes of depression in 2015, and the World Health Organization (WHO) indicate that around 800,000 suicides take place worldwide each year. Depression can affect the way a person performs even the most basic daily activities, and it can severely impact productivity and general well-being. Mary Kay Lobo, Ph.D., alongside other researchers from the University of Maryland School of Medicine in Baltimore, conducted a study focusing on a gene known as Slc6a15. This gene has been thought to play an important role in the onset of depression. Dr. Lobo and colleagues set out to uncover the specifics of how this gene's activity levels might affect mood swings.

Low gene expression in over-stressed mice

In a previous study published in Nature Neuroscience, Dr. Lobo and collaborators had concluded that the Slc6a15 gene was most commonly found in a type of neuron located in the nucleus accumbens, which is a region of the brain largely responsible for the brain's reward circuit. The neurons found in the nucleus accumbens dictate whether, and to what extent, we feel pleasure when we perform normally satisfying activities, such as eating, drinking, or spending time with friends. The nucleus accumbens works with two main neurotransmitters, or chemical messengers, called serotonin and dopamine. These regulate our happiness levels and how well we handle stress.

Dr. Lobo and her colleagues studied D2 neurons, a set of neurons in the nucleus accumbens that are sensitive to dopamine. They started their research by monitoring male mice susceptible to depression, focusing on the importance of the Slc6a15 gene in D2 neurons in adjusting the specimen's response to intense stress. The researchers found that mice that did not naturally respond well to stress had significantly lower Slc6a15 gene activity levels in their D2 neurons when introduced to critical situations. To understand the impact of less active Slc6a15 genes versus highly active ones, the scientists also monitored mice whose Slc6a15 gene activity levels had been artificially brought down. It was observed that these mice also failed to respond well when exposed to stressful situations.

Higher gene activity improves resilience

Finally, the researchers studied mice whose Slc6a15 gene activity levels had been intensified. These mice, by contrast, responded well when faced with stress factors. Then, in order to test for Slc6a15 gene expression, the team examined the brains of people who had experienced major depression or committed suicide. They obtained similar results for humans susceptible to depression: the activity levels of the Slc6a15 gene in D2 neurons were significantly reduced in people who had little stress resilience.

The findings suggest that the answer to depression may lie in how active the Slc6a15 gene is, and that artificially enhancing its expression in the D2 neurons may improve the way in which stress is handled. "[...] people with altered levels of this gene in certain brain regions may have a much higher risk for depression and other emotional disorders related to stress," says Dr. Lobo. Despite their detailed study, the scientists are still unsure of how the Slc6a15 gene functions. They surmise that the gene's activity levels may affect the balance of neurotransmitters such as dopamine, but further research will be necessary to confirm this theory.

 

Source: MedicalNewsToday/Maria Cohut

10.07.2017

Read all latest stories

Related articles

Photo

Promising preclinical study results

Epilepsy: Gene therapy shows long-term suppression of seizures

Teams of researchers from Charité – Universitätsmedizin Berlin and the Medical University of Innsbruck have developed a new therapeutic concept for the treatment of temporal lobe epilepsy. It…

Photo

Psychiatry

Leonardo da Vinci: pure genius or ADHD?

Professor Marco Catani suggests the best explanation for Leonardo da Vinci's inability to finish his works is that the great artist may have had Attention Deficit and Hyperactivity Disorder. Leonardo…

Photo

Obsessive compulsive disorder

Targeted deep brain stimulation reduces OCD symptoms

The debilitating behaviours and all-consuming thoughts which affect people with severe obsessive compulsive disorder (OCD), could be significantly improved with targeted deep brain stimulation,…

Related products

Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
Agena Bioscience - MassARRAY Colon Panel

Amplification/Detection

Agena Bioscience - MassARRAY Colon Panel

Agena Bioscience GmbH
Eppendorf – BioSpectrometer fluroescence

Research Use Only (RUO)

Eppendorf – BioSpectrometer fluroescence

Eppendorf AG
Eppendorf – μCuvette G1.0

Research Use Only (RUO)

Eppendorf – μCuvette G1.0

Eppendorf AG
Orion Diagnostica Oy – Orion GenRead

Amplification

Orion Diagnostica Oy – Orion GenRead

Orion Diagnostics Oy